Lysoway Therapeutics
PrivateLast Round
Grant
Jun 1, 2026
Total Funding Raised
$28.33M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Lysoway Therapeutics is a biopharmaceutical company that develops small-molecule modulators of lysosomal ion channels to treat neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lysoway Therapeutics Comparables
Compare Lysoway Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Libra Therapeutics | 86% | |
| Casma Therapeutics | 85% | |
| Tenvie Therapeutics | 80% | |
Lysoway Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2026 | ||||
| Grant | Aug 5, 2025 | ||||
| Grant | Jan 5, 2023 | ||||
| Series A | Oct 5, 2022 |
Key People
Founding team and executive leadership
Lysoway Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series A |
| Highlight Capital | Series A |
| Bencao Capital | Series A |
| Oceanpine Capital | Series A |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| The Silverstein Foundation for Parkinson's with GBA | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 38% MoM, reaching 1.5K.
- Jun 1, 2026
Received $3M from The Michael J. Fox Foundation.
Lysoway Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lysoway Therapeutics's valuation, stock price, and market status.